ICMRA urges cut to animal testing while HHS launches ARPA-H SURPASS program to accelerate clinical trials
International Coalition of Medicines Regulatory Authorities released a joint statement urging drug makers and national control labs to cut back on animal testing throughout a medicine’s development.
The coalition also asked regulators to scrutinize any proposals that would keep animals in batch‑release testing, promoting alternative methods wherever possible.
In related regulatory news, the U.S. Department of Health and Human Services announced a new ARPA‑H initiative called the Simulation‑augmented, Real‑time Platform Adaptive Seamless Trials (SURPASS) program. The effort aims to redesign clinical trials to be more efficient and bring therapies to market faster.
This writeup was produced by pharmadog from original reporting by raps.
Original headline: “ICMRA joins call to replace animal testing with alternative approaches”
read at raps ↗
comments(0)
5-min edit window · permanent after that